The news comes as drug discovery rates are declining, the price of bringing a drug to market is increasing, and return on investment (ROI) on R&D is expected to hit 0% in the next few years.
Scientists at the University of Birmingham have announced the discovery of a protein that could hold the key to novel gene therapies for skin problems such as psoriasis.